书目名称 | Lysosomal Storage Disorders |
编辑 | John A. Barranger,Mario A. Cabrera-Salazar |
视频video | http://file.papertrans.cn/590/589248/589248.mp4 |
概述 | Describes the nature of the lysosomal dysfunction and diseases as well as potential future treatments and therapies.Provides the historical evolution of the field.Organized as a textbook with disease- |
图书封面 |  |
描述 | Scientific progress has been rapid in lysosomal biology during the last six decades. Its application to human disease is nothing less than spectacular. In no other group of disorders has knowledge and clinical utility progressed so speedily. Recall that the organelle was described in just 1955. Since then, the biochemical alterations and storage materials were described, the enzyme deficiencies discovered, the gene coding of these glycoproteins cloned and thousands of mutations defined. These advances have resulted in highly improved diagnosis for more than 50 diseases. For five diseases, including the most common lysosomal storage disorder, molecular therapy is a reality, extremely effective and very safe. This higher plateau of medical approaches to human disease is something to which all translational scientists aspire and only a few actually witness. The relief of pain and suffering is a tribute to the ideas and work of many dedicated investigators. Much of that work is presented in this text. Despite our ability to treat some of these diseases through enzyme replacement therapy (ERT) and, accurately define different diseases that look alike, there is much to be learned about l |
出版日期 | Book 2007 |
关键词 | Glycogen; Lipid; Polysaccharid; enzymes; gene therapy; gene transfer; genes; genetics |
版次 | 1 |
doi | https://doi.org/10.1007/978-0-387-70909-3 |
isbn_softcover | 978-1-4419-4366-8 |
isbn_ebook | 978-0-387-70909-3 |
copyright | Springer-Verlag US 2007 |